Medicare IVIG Access Enhancement Act of 2025

Bill Number

HR 1143

Introduced

Feb 7, 2025

Latest Action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be ...

Sponsor

Cosponsors

Topics

Drug therapy Health Health care costs and insurance Health care coverage and access Medicare Neurological disorders

Full Text

View Full Bill Text

Votes

Summary

Medicare IVIG Access Enhancement Act of 2025

This bill provides for Medicare coverage of in-home administration of intravenous immune globulin to treat chronic inflammatory demyelinating polyneuropathy (CIDP) or multifocal motor neuropathy. (CIDP is an autoimmune condition that causes symptoms such as muscle weakness and numbness; multifocal motor neuropathy is a variant of CIDP that only causes asymmetric muscle weakness.)

Actions

Feb 7, 2025

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 7, 2025

Introduced in House

Amendments

Related Bills